TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Rhinosaurus medicus AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
20
|
552
|
670 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
-53
|
284
|
448 |
| EBITDA |
-52
|
284
|
449 |
| Total assets |
92
|
380
|
582 |
| Current assets |
92
|
380
|
582 |
| Current liabilities |
24
|
59
|
136 |
| Equity capital |
68
|
321
|
446 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.9%
|
84.5%
|
76.6% |
| Turnover per employee |
20
|
552
|
670 |
| Profit as a percentage of turnover |
-265.0%
|
51.4%
|
66.9% |
| Return on assets (ROA) |
-56.5%
|
74.7%
|
77.0% |
| Current ratio |
383.3%
|
644.1%
|
427.9% |
| Return on equity (ROE) |
-77.9%
|
88.5%
|
100.4% |
| Change turnover |
-532
|
-118
|
241 |
| Change turnover % |
-96%
|
-18%
|
56% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.